Biosimilars: What will it take to deliver on their promise?Published: Jan. 2020 Biosimilars nearly identical versions of biologic drugs have been heralded as a salve for the skyrocketing costs of prescription medications used to treat a wide variety of diseases. But so far they have been a disappointment. In this STAT Report, we dive into the legal, manufacturing, and regulatory challenges that biosimilars currently face and the possible solutions that could help biosimilars deliver on their promise. This